Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Richard Ermel"'
Autor:
Zhiqiang Wang, Chunxiao Zhang, Charles David Warden, Zheng Liu, Yate-Ching Yuan, Chao Guo, Charles Wang, Jinhui Wang, Xiwei Wu, Richard Ermel, Steven L. Vonderfecht, Xiuli Wang, Christine Brown, Stephen Forman, Yaling Yang, M. James You, WenYong Chen
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-15 (2022)
Studies employing serial bone marrow transplantation in mice show that Sirt1 knockout improves quiescence maintenance and function of aging hematopoietic stem cells. Sirt1 loss also prevents the development of age-dependent B/myeloid mixed phenotype
Externí odkaz:
https://doaj.org/article/9d0e1dc32e3944ccbb5ec887342c8d2e
Autor:
Richard Ermel, WenYong Chen, Alison Buck, Young L. Kim, Taisen Hao, Zhiqiang Wang, Steven Vonderfecht, Chunxiao Zhang
Publikováno v:
Oncogene
Chronic myeloid leukemia (CML) is an age-dependent blood malignancy. Like many other age-dependent human diseases, laboratory animal research of CML uses young mice that do not factor in the influence of aging. To understand how aging may impact anim
Publikováno v:
Lab animal. 39(8)
Publikováno v:
Lab animal. 38(1)
Publikováno v:
Cancer Research. 75:4403-4403
Cell membrane proteins such as integrins are crucial for cell-cell recognition, binding and communication, cell-stromal interaction and adhesion, tumor invasion and metastasis. It was reported that cell-size hydrophobic beads coated with tumor membra
Autor:
Eugene Roberts, Richard Ermel, Yan Wang, Abraham P. Lee, Meng-Yin Hsieh, Derek Vallejo, Jun Wu
Publikováno v:
Cancer Research. 74:5412-5412
Canine cancers develop in immunocompetent environments and share many similar features observed in human cancers, such as long periods of latency for initiation, progression and development, metastasis, acquired drug resistance and recurrence. Osteos
Publikováno v:
Lab Animal. 39:234-235
Autor:
Richard Ermel, Mahesh Jonnalagadda
Publikováno v:
Lab Animal. 38:113-114
Autor:
Mahesh Jonnalagadda, Richard Ermel
Publikováno v:
Lab Animal. 41:250-250